6Monnet I;Soulié P;de Cremoux H.Phase I /II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer[J],2001(02).
6Sperandi F, Melotti B, Martoni AA. Gemcitabine ( GEM ) ( day 1-8 ) plus carboplatin (CBDCA) ( day2 ) for the treatment of advanced non-small cell lung cancer(aNSCLC) in elderly or poor performance status(PS) patients(pts) [J]. J Clin Oncol,2007,2.5(18) :18116.
7Eiseahauer EA, Therasse P, Bogaerts J, et al. New response evalua- tion criteria in solid tumoum: revised RECIST guideline( version 1.1 ) [J]. Eur J Caner,2009,45(2) :228-247.
8Davidoff A J, Tang M, Seal B, et al. Chemotherapy and survival ben- efit in elderly patients with advanced non-small-cell lung cancer [J]. J Clin 0ncol,2010,28(13) :2191-2197.
9Azzoli CG, Temin S, Aliff T, et al. 2011 focused update of 2009 American society of clinical oncology clinical practice guideline update on chemotherapy for stage 1V non-small-cell lung cancer [J]. J Clin Oncol,2011,29(28) :3825-3831.
10Quoix EA, Oster J, Westeel V, et al. Weekly paclitaxel combined with monthly carboplatin wersus single-agent therapy in patients age 70 to 89 : IFCT-O501 randomized phase II[ study in advanced non-small cell lung cancer (NSCLC) [ J ]. J Clin Oncol, 2010,28 (18):2.
